Unclaimed brand
QBiotics, Australian life sciences company, specialising in small cell signaling molecules. Established programs in oncology (tigilanol tiglate), wound healing (EBC-1013), plus preclinical antibiotics. Drug discovery platform Ecologic and Phenotypic drug screening.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#679FD5
Danube
103, 159, 213
209, 57, 62
52, 25, 0, 16
#A5CDEB
Cornflower
165, 205, 235
206, 64, 78
30, 13, 0, 8
#383838
Mine Shaft
56, 56, 56
0, 0, 22
0, 0, 0, 78
QBiotics is a brand that specializes in plant-derived, cell signaling, small molecules that are used to treat challenging medical conditions such as cancer and chronic wounds. They are dedicated to harnessing the power of nature to improve lives. QBiotics offers a range of products and services in the field of pharmaceuticals.
Their lead drug, tigilanol tiglate, is a small molecule anticancer pharmaceutical that targets a variety of solid tumors in multiple species. It is approved to treat canine mast cell tumors and is marketed in the USA, UK, EU, and Australia under the brand name STELFONTA®. QBiotics is also developing EBC-1013, their next lead drug, for the treatment of debilitating acute and chronic wounds.
What sets QBiotics apart is their simultaneous development of products for both veterinary and human applications. This approach facilitates early technology validation and generates revenue through quicker-to-market veterinary products. With a team of experienced professionals and a commitment to improving lives, QBiotics is at the forefront of innovative pharmaceutical solutions
Company type
Privately Held
Year founded
2000
Company size
51-200 employees
